Saghmos Therapeutics Revenue

Biotechnology Research • Greenwich, Connecticut, United States • 1-10 Employees

Saghmos Therapeutics revenue & valuation

Annual revenue	$342,220
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,100,000
Total funding	No funding

Key Contact at Saghmos Therapeutics

Shalini Cornelio

Founder and Chief Operating Officer

Company overview

Headquarters	Greenwich, Connecticut, United States
Phone number	+19145223885
NAICS	541714
Keywords	Diabetes, PCI, Cardiovascular, Chronic Kidney Disease, CKD, Heart Failure, Mace, Acute Kidney Injury, Make, AKI, Cardiometabolic, Phase3, Cardiorenal, Acute Kidney Failure, Egfr, Unstable Angina
Founded	2016
Employees	1-10
Socials

About Saghmos Therapeutics

Saghmos Therapeutics is a privately held biopharmaceuticals company with a Phase 3-ready cardiorenal metabolic modulator ST-62516 (trimetazidine). Saghmos’ IND for ST-62516 was cleared by the FDA in July 2023. ST-62516 is being developed to reduce the risk of Acute Kidney Injury (AKI) and Major Adverse Cardiac and Kidney Events (MACKE) after contrast procedures such as percutaneous coronary intervention (PCI). This is an area of high unmet need. Patients with pre-existing Chronic Kidney Disease (CKD) and comorbidities such as diabetes and heart disease are at high risk of complications, including heart failure and progression of kidney disease, leading to prolonged hospitalization and need for dialysis. There are no approved pharmacologic agents to prevent or treat the problem. Saghmos Therapeutics has an issued US patent providing exclusivity through 2037 for the prevention and treatment of acute kidney injury after contrast procedures.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

Saghmos Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Saghmos Therapeutics has never raised funding before.

Frequently asked questions

Saghmos Therapeutics is located in Greenwich, Connecticut, US.

You can reach Saghmos Therapeutics at +19145223885.

Saghmos Therapeutics generates an estimated annual revenue of $342,220. This revenue figure reflects the company's market position and business performance in its industry.

Saghmos Therapeutics has an estimated valuation of $1,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Saghmos Therapeutics was founded in 2016, making it 10 years old. The company has established itself as a significant player in its industry over this time.

Saghmos Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Saghmos Therapeutics

Shalini Cornelio

Founder and Chief Operating Officer

4.8

40,000 users